ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases

References

• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–29
   PubMed Web of Science ®Google Scholar
• Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease (IBD) in a province of Western Hungary with disease phenotypes: results of a 25-year follow-up study. World J Gastroenterol 2003; 9: 2300–7
   PubMed Web of Science ®Google Scholar
• Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, et al. Striking elevation in the incidence and prevalence of inflammatory bowel disease in a province of Western Hungary between 1977–2001. World J Gastroenterology 2004; 10: 404–409
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Lakatos L. Current concepts on the genetics and pharmacogenetics of inflammatory bowel disease: do they help in clinical management?. Curr Genom 2006; 7: 149–62
   Web of Science ®Google Scholar
• Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z, et al. Hungarian IBD Study Group. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn disease: phenotype-genotype correlations. World J Gastroenterol 2005; 11: 1489–95
   PubMed Web of Science ®Google Scholar
• Ho GT, Moodie FM, Satsangi J. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?. Gut 2003; 52: 759–66
   PubMed Web of Science ®Google Scholar
• Fromm MF. The influence of MDR1 polymorphism on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev 2002; 54: 1295–310
   PubMed Web of Science ®Google Scholar
• Farrell RJ, Murphy A, Long A, Donelly S, Cherikuri A, O'Toole D, et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 2000; 118: 279–88
   PubMed Web of Science ®Google Scholar
• Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multi drug resistance gene MDR1a, spontaneously develop colitis. J Immunol 1998; 161: 5733–44
   PubMed Web of Science ®Google Scholar
• Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, et al. MDR1 Ala 893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 2003; 73: 1282–92
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–8
   PubMed Web of Science ®Google Scholar
• Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitits. Gastroenterology 2003; 124: 26–33
   PubMed Web of Science ®Google Scholar
• Ho GT, Nimmo ER, Tenesa A, Fennell J, Drummond H, Mowat C, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behaviour in ulcerative colitis. Gastroenterology 2005; 128: 288–96
   PubMed Web of Science ®Google Scholar
• Urcelay E, Mendoza JL, Martin MC, Mas A, Martinez A, Taxonera C, et al. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis 2006; 12: 33–7
   PubMed Web of Science ®Google Scholar
• Rocchi E, Khodjakov A, Volk EL, Yang CH, Litman T, Bates SE, et al. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun 2000; 27: 42–6
   Web of Science ®Google Scholar
• Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001; 61: 3458–64
   PubMed Web of Science ®Google Scholar
• Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, et al. A multidrug resistance transporter from the human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998; 95: 15665–70
   PubMed Web of Science ®Google Scholar
• Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 2006; 46: 381–410
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Ozvegy-Laczka C, Nemet K, Varadi A. ABCG2: a transporter for all seasons. FEBS Lett 2004; 567: 116–20
   PubMed Web of Science ®Google Scholar
• Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res 2002; 62: 5035–40
   PubMed Web of Science ®Google Scholar
• Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. ABCG2 transports sulfated conjugates of steroids and xenoiotics. J Biol Chem 2003; 278: 22644–9
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, et al. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 2006; 290: E798–807
   PubMed Web of Science ®Google Scholar
• Tamura A, Watanabe M, Saito H, Nakagawa H, Kamachi T, Okura I, et al. Functional validation of the genetic polymorphisms of human ABC transporter ABCG2: identification of alleles that are defective in porphyrin transport. Mol Pharmacol 2006; 70: 287–96
   PubMed Web of Science ®Google Scholar
• Polgar O, Ozvegy-Laczka C, Robey RW, Morisaki K, Okada M, Tamaki A, et al. Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization. Biochemistry 2006; 45: 5251–60
   PubMed Web of Science ®Google Scholar
• Sparreboom A, Gelderblom H, Marsh S, Ahluwalia R, Obach R, Principe P, et al. Diflomotecan pharmacokinetics in relation to ABCG2 421C > A genotype. Clin Pharmacol Ther 2004; 76: 38–44
   PubMed Web of Science ®Google Scholar
• Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, et al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002; 123: 108–11
   Web of Science ®Google Scholar
• Urcelay E, Mendoza JL, Martinez A, Fernandez L, Taxonera C, Diaz-Rubio M, et al. IBD5 polymorphisms in inflammatory bowel disease: association with response to infiximab. World J Gastroenterol 2005; 11: 1187–92
   PubMed Web of Science ®Google Scholar
• McGovern D, Ahmad T, Van Heel D, Negora K, Jewell D, et al. Cytochrome p450 and multidrug-resistance gene 1 (MDR1) polymorphisms: prediction of the need for colectomy in ulcerative colitis?. Gastroenterology 2002; 122: W1313
   Web of Science ®Google Scholar
• Lakatos PL, Fischer S, Claes K, Kovacs A, Molnar T, Altorjay I, et al. Hungarian IBD Study Group. DLG5 R30Q is not associated with inflammatory bowel disease in Hungarian IBD patients, but predicts clinical response to steroids in Crohn's disease. Inflamm Bowel Dis 2006; 12: 362–8
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol ;24 Suppl 1989; 170: 2–6
   Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna. Inflamm Bowel Dis ;6 1998; 2000: 8–15
   Google Scholar
• Oselin K, Gerloff T, Mrozikiewicz PM, Pahkla R, Roots I. MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes. Fundam Clin Pharmacol 2003; 17: 463–9
   PubMed Web of Science ®Google Scholar
• Arjomand-Nahad F, Diefenbach K, Landt O, Gaikovitch E, Roots I. Genotyping of the triallelic variant G2677T/A in MDR1 using LightCycler with locked-nucleic-acid-modified hybridization probes. Anal Biochem 2004; 334: 201–3
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics methods and protocols: methods in molecular biology, S Krawetz, S. Misener. Humana Press, Totowa, N. J 2000; 365–86
   Google Scholar
• Szilvasi A, Andrikovics H, Kalmar L, Bors A, Tordai A. Asymmetric PCR increases efficiency of melting peak analysis on the LightCycler. Clin Biochem 2005; 38: 727–30
   PubMed Web of Science ®Google Scholar
• Croucher PJ, Mascheretti S, Foelsch UR, Hampe J, Schreiber S. Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology 2003; 125: 1919–20
   PubMed Web of Science ®Google Scholar
• Oostenburg LE, Dijkstra G, Nolte IM, Van Dullemen HM, Oosterom E, Faber KN, et al. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand J Gastroenterol 2006; 10: 1174–82
   Web of Science ®Google Scholar
• Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol 2006; 12: 3636–44
   PubMed Web of Science ®Google Scholar
• Ho GT, Soranzo N, Nimmo ER, Tenesa A, Goldstein DG, Satsangi J. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet 2006; 15: 797–805
   PubMed Web of Science ®Google Scholar
• Poto(nik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 2004; 5: 530–9
   PubMed Web of Science ®Google Scholar
• Katsanos KH, Ferrante M, Henckaerts L, Pierik M, Claes K, Van Schuerbeek N, , et al. The single nucleotide polymorphism C3435T in the MDR1 gene predicts steroid tapering in inflammatory bowel disease. Gastroenterology 2006;130 Suppl S:T1994.
   Web of Science ®Google Scholar